avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.20 | MEIS2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEIS2 | hg38_v1_chr15_-_37101205_37101326, hg38_v1_chr15_-_37100523_37100556 | -0.23 | 8.1e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.7 | 50.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
16.2 | 64.7 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
13.9 | 41.8 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
11.4 | 34.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
10.8 | 32.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
10.5 | 84.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
8.9 | 80.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
8.4 | 8.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
8.3 | 24.8 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
8.3 | 24.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
8.1 | 8.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
7.3 | 36.6 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
7.0 | 14.0 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
6.9 | 117.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
6.8 | 13.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
6.7 | 33.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
6.6 | 19.9 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
6.6 | 19.7 | GO:0030185 | nitric oxide transport(GO:0030185) |
6.4 | 25.7 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
6.3 | 19.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
6.2 | 6.2 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
6.2 | 30.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
6.1 | 18.2 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
6.0 | 6.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
5.9 | 17.7 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
5.9 | 17.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.9 | 17.6 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
5.7 | 17.0 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
5.5 | 16.6 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
5.5 | 16.5 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
5.3 | 15.8 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
5.2 | 20.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
5.1 | 20.5 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
5.1 | 15.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
4.9 | 29.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
4.9 | 19.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
4.9 | 19.6 | GO:1990502 | dense core granule maturation(GO:1990502) |
4.9 | 24.4 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
4.9 | 4.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
4.8 | 19.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
4.7 | 60.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
4.6 | 4.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
4.6 | 13.7 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
4.5 | 18.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
4.5 | 13.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
4.4 | 35.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
4.3 | 21.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
4.3 | 17.0 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
4.2 | 12.6 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
4.2 | 16.6 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
4.1 | 16.5 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
4.1 | 12.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
4.1 | 12.2 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
4.1 | 12.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
4.1 | 12.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
4.0 | 12.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
4.0 | 12.0 | GO:0039023 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
4.0 | 39.8 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
3.9 | 27.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.9 | 15.5 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
3.8 | 15.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
3.8 | 7.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
3.7 | 18.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
3.6 | 10.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
3.6 | 10.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
3.6 | 25.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
3.5 | 7.0 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
3.5 | 3.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.5 | 20.9 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
3.4 | 6.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
3.4 | 10.3 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
3.4 | 57.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.4 | 61.0 | GO:0015671 | oxygen transport(GO:0015671) |
3.4 | 37.2 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
3.4 | 13.5 | GO:0015793 | glycerol transport(GO:0015793) |
3.4 | 16.8 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
3.3 | 23.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.3 | 9.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.2 | 13.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
3.2 | 9.7 | GO:0060005 | vestibular reflex(GO:0060005) |
3.2 | 22.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.2 | 12.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
3.2 | 28.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
3.1 | 9.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
3.1 | 21.9 | GO:0051597 | response to methylmercury(GO:0051597) |
3.1 | 9.4 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
3.1 | 37.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
3.1 | 12.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
3.1 | 9.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
3.1 | 18.5 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
3.0 | 9.1 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
3.0 | 39.5 | GO:0015074 | DNA integration(GO:0015074) |
3.0 | 18.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
3.0 | 6.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
3.0 | 36.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.0 | 26.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
3.0 | 14.9 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
3.0 | 62.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
3.0 | 20.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
3.0 | 5.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
3.0 | 26.6 | GO:0070543 | response to linoleic acid(GO:0070543) |
2.9 | 14.7 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
2.9 | 14.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.9 | 11.7 | GO:0072011 | glomerular endothelium development(GO:0072011) |
2.9 | 11.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.9 | 14.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.9 | 8.6 | GO:0018377 | protein myristoylation(GO:0018377) |
2.8 | 5.7 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
2.8 | 11.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
2.8 | 2.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
2.8 | 13.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
2.8 | 11.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
2.8 | 8.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
2.7 | 11.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.7 | 38.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.7 | 8.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
2.7 | 24.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.7 | 16.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
2.7 | 8.1 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
2.7 | 18.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.7 | 16.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.7 | 10.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
2.6 | 13.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
2.6 | 5.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
2.6 | 10.6 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
2.6 | 34.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
2.6 | 7.9 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
2.6 | 10.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
2.6 | 7.9 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
2.6 | 325.0 | GO:0031295 | T cell costimulation(GO:0031295) |
2.6 | 5.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
2.6 | 10.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
2.6 | 43.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.5 | 17.8 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
2.5 | 10.1 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
2.5 | 10.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
2.5 | 15.1 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
2.5 | 12.5 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
2.5 | 9.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.5 | 12.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.4 | 22.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.4 | 9.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.4 | 2.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.4 | 7.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
2.4 | 7.2 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
2.4 | 11.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
2.4 | 2.4 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
2.4 | 16.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.4 | 11.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
2.4 | 9.5 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.3 | 21.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
2.3 | 9.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
2.3 | 4.6 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
2.3 | 9.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
2.3 | 16.1 | GO:0015705 | iodide transport(GO:0015705) |
2.3 | 4.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
2.3 | 11.4 | GO:0030070 | insulin processing(GO:0030070) |
2.3 | 29.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
2.3 | 6.8 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
2.3 | 6.8 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
2.3 | 6.8 | GO:0060875 | subpallium cell proliferation in forebrain(GO:0022012) lateral ganglionic eminence cell proliferation(GO:0022018) lambdoid suture morphogenesis(GO:0060366) sagittal suture morphogenesis(GO:0060367) anterior semicircular canal development(GO:0060873) lateral semicircular canal development(GO:0060875) |
2.2 | 9.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.2 | 4.5 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
2.2 | 6.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
2.2 | 6.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
2.2 | 11.1 | GO:0035106 | operant conditioning(GO:0035106) |
2.2 | 22.1 | GO:0048102 | autophagic cell death(GO:0048102) |
2.2 | 15.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
2.2 | 2.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
2.2 | 61.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.2 | 28.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.1 | 12.8 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
2.1 | 4.2 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
2.1 | 8.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
2.1 | 12.7 | GO:0038016 | insulin receptor internalization(GO:0038016) |
2.1 | 2.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
2.1 | 6.3 | GO:0014873 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.1 | 2.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
2.1 | 6.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
2.1 | 26.8 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
2.1 | 10.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.1 | 12.3 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
2.0 | 12.2 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
2.0 | 8.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
2.0 | 10.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.0 | 8.0 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
2.0 | 8.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
2.0 | 6.0 | GO:0008078 | mesodermal cell migration(GO:0008078) axial mesoderm morphogenesis(GO:0048319) |
2.0 | 29.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.0 | 5.9 | GO:0061107 | seminal vesicle development(GO:0061107) |
2.0 | 45.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
2.0 | 9.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
2.0 | 5.9 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.0 | 9.8 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
1.9 | 7.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 7.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.9 | 23.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.9 | 5.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
1.9 | 23.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
1.9 | 5.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.9 | 19.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.9 | 5.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.9 | 7.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.9 | 9.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.9 | 1.9 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
1.9 | 7.5 | GO:0071110 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
1.9 | 15.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.9 | 5.6 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.9 | 13.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.8 | 11.1 | GO:0016926 | protein desumoylation(GO:0016926) |
1.8 | 1.8 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.8 | 9.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.8 | 20.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.8 | 253.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.8 | 21.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.8 | 7.2 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
1.8 | 3.6 | GO:0008272 | sulfate transport(GO:0008272) |
1.8 | 7.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.8 | 1.8 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
1.8 | 7.1 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
1.8 | 5.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.8 | 32.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.8 | 3.5 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
1.8 | 3.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
1.8 | 3.5 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
1.7 | 3.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.7 | 13.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.7 | 5.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
1.7 | 1.7 | GO:1990641 | response to iron ion starvation(GO:1990641) |
1.7 | 8.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.7 | 1.7 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
1.7 | 17.1 | GO:0044117 | growth of symbiont in host(GO:0044117) |
1.7 | 5.0 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
1.7 | 5.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.7 | 11.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.7 | 9.9 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
1.7 | 5.0 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.6 | 1.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.6 | 8.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.6 | 1.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.6 | 9.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.6 | 9.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.6 | 4.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.6 | 7.9 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
1.6 | 6.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.6 | 3.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.6 | 4.7 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.6 | 3.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.6 | 4.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
1.6 | 9.4 | GO:0007320 | insemination(GO:0007320) |
1.6 | 7.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.6 | 4.7 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
1.5 | 10.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.5 | 1.5 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
1.5 | 10.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.5 | 4.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.5 | 3.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.5 | 6.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.5 | 3.0 | GO:0002215 | defense response to nematode(GO:0002215) |
1.5 | 4.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.5 | 14.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.5 | 8.9 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
1.5 | 10.4 | GO:0048241 | epinephrine transport(GO:0048241) |
1.5 | 3.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.5 | 4.5 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
1.5 | 10.4 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.5 | 7.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.5 | 8.8 | GO:1903232 | melanosome assembly(GO:1903232) |
1.5 | 8.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.5 | 8.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.5 | 5.8 | GO:0019086 | late viral transcription(GO:0019086) |
1.5 | 4.4 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
1.5 | 5.8 | GO:0002357 | defense response to tumor cell(GO:0002357) |
1.5 | 33.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
1.5 | 4.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
1.5 | 5.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.4 | 4.3 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
1.4 | 25.9 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.4 | 4.3 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
1.4 | 4.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.4 | 2.8 | GO:0061056 | sclerotome development(GO:0061056) |
1.4 | 8.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.4 | 7.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.4 | 12.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.4 | 8.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.4 | 11.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.4 | 4.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
1.4 | 16.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.4 | 8.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.4 | 8.3 | GO:0050955 | thermoception(GO:0050955) |
1.4 | 4.1 | GO:0045554 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
1.4 | 5.5 | GO:0035627 | ceramide transport(GO:0035627) |
1.4 | 5.5 | GO:0015942 | formate metabolic process(GO:0015942) |
1.4 | 10.9 | GO:0061709 | reticulophagy(GO:0061709) |
1.4 | 4.1 | GO:0051414 | response to cortisol(GO:0051414) |
1.4 | 14.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.4 | 4.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.4 | 9.5 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
1.3 | 4.0 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
1.3 | 1.3 | GO:0070781 | response to biotin(GO:0070781) |
1.3 | 2.7 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.3 | 8.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.3 | 8.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.3 | 1.3 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
1.3 | 6.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.3 | 5.3 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
1.3 | 4.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.3 | 13.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.3 | 10.6 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
1.3 | 2.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
1.3 | 5.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
1.3 | 5.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
1.3 | 7.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.3 | 20.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.3 | 6.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
1.3 | 6.3 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.3 | 11.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.3 | 7.5 | GO:0018343 | protein farnesylation(GO:0018343) |
1.3 | 3.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
1.2 | 5.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
1.2 | 14.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.2 | 1.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.2 | 7.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.2 | 9.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.2 | 3.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.2 | 3.7 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.2 | 19.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.2 | 13.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
1.2 | 2.4 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
1.2 | 4.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
1.2 | 18.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.2 | 3.6 | GO:0007538 | primary sex determination(GO:0007538) |
1.2 | 13.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.2 | 7.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 3.6 | GO:2000366 | cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
1.2 | 5.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.2 | 2.4 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
1.2 | 3.5 | GO:0071529 | cementum mineralization(GO:0071529) |
1.2 | 10.6 | GO:0000012 | single strand break repair(GO:0000012) |
1.2 | 3.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.2 | 9.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.2 | 6.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 2.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.2 | 4.6 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
1.1 | 2.3 | GO:1905237 | maintenance of blood-brain barrier(GO:0035633) response to cyclosporin A(GO:1905237) |
1.1 | 19.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.1 | 3.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
1.1 | 3.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.1 | 18.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.1 | 11.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.1 | 6.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.1 | 3.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.1 | 13.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.1 | 17.8 | GO:0015874 | norepinephrine transport(GO:0015874) |
1.1 | 5.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.1 | 11.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.1 | 4.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.1 | 6.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.1 | 4.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.1 | 4.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.1 | 7.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 7.6 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
1.1 | 108.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
1.1 | 3.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
1.1 | 2.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.1 | 3.2 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
1.1 | 1.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.1 | 2.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.1 | 6.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.1 | 27.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.1 | 6.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
1.1 | 4.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.1 | 7.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
1.1 | 17.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.1 | 7.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.1 | 4.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.0 | 22.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
1.0 | 3.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
1.0 | 6.3 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
1.0 | 8.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.0 | 4.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
1.0 | 15.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 10.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.0 | 12.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 12.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.0 | 4.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.0 | 4.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.0 | 3.0 | GO:0002708 | positive regulation of lymphocyte mediated immunity(GO:0002708) |
1.0 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 5.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.0 | 8.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
1.0 | 3.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
1.0 | 6.0 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
1.0 | 7.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.0 | 2.0 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
1.0 | 3.0 | GO:0070079 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
1.0 | 4.0 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
1.0 | 7.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.0 | 10.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.0 | 17.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.0 | 2.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.0 | 2.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.0 | 2.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.0 | 4.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.0 | 4.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 7.8 | GO:0051026 | chiasma assembly(GO:0051026) |
1.0 | 7.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 1.0 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
1.0 | 11.6 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.0 | 12.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.0 | 1.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.0 | 1.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.0 | 2.9 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
1.0 | 3.8 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
1.0 | 1.9 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.0 | 6.7 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.9 | 16.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.9 | 3.8 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.9 | 26.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 23.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.9 | 6.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.9 | 7.5 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.9 | 6.6 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.9 | 1.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.9 | 55.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.9 | 3.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.9 | 4.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.9 | 33.2 | GO:0034080 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.9 | 1.8 | GO:0097272 | ammonia homeostasis(GO:0097272) |
0.9 | 23.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.9 | 22.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.9 | 5.5 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.9 | 8.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.9 | 5.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.9 | 8.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.9 | 7.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.9 | 2.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 10.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.9 | 1.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.9 | 3.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.9 | 4.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.9 | 2.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.9 | 24.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.9 | 3.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.9 | 0.9 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.9 | 1.7 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.9 | 4.4 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.9 | 5.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.9 | 3.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.9 | 9.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 3.5 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.9 | 2.6 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.9 | 12.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.9 | 0.9 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
0.9 | 5.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.9 | 6.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.9 | 25.6 | GO:0097503 | sialylation(GO:0097503) |
0.8 | 2.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.8 | 9.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 3.3 | GO:0010157 | response to chlorate(GO:0010157) |
0.8 | 2.5 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.8 | 10.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.8 | 5.8 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.8 | 6.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.8 | 2.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.8 | 2.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 | 4.8 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.8 | 20.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.8 | 2.4 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.8 | 4.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 9.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.8 | 20.6 | GO:0051181 | cofactor transport(GO:0051181) |
0.8 | 2.4 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.8 | 2.4 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
0.8 | 4.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.8 | 5.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 11.8 | GO:0002021 | response to dietary excess(GO:0002021) |
0.8 | 10.2 | GO:0045008 | depyrimidination(GO:0045008) |
0.8 | 7.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.8 | 18.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.8 | 1.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.8 | 3.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 23.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.8 | 14.0 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.8 | 5.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.8 | 3.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.8 | 9.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 9.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.8 | 19.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.8 | 3.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 8.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.8 | 1.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.8 | 2.3 | GO:0015871 | choline transport(GO:0015871) |
0.8 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.8 | 14.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.8 | 2.3 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.7 | 3.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.7 | 5.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.7 | 3.0 | GO:0044256 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.7 | 20.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 0.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 2.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.7 | 20.0 | GO:0048665 | neuron fate specification(GO:0048665) |
0.7 | 2.2 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.7 | 18.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.7 | 1.5 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.7 | 4.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.7 | 2.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.7 | 2.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.7 | 3.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 3.6 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 | 5.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.7 | 3.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.7 | 2.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 10.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.7 | 3.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 8.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 6.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.7 | 2.9 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 2.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.7 | 4.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.7 | 4.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.7 | 2.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.7 | 3.5 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.7 | 4.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.7 | 1.4 | GO:0048840 | otolith development(GO:0048840) |
0.7 | 1.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.7 | 2.8 | GO:0039506 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.7 | 1.4 | GO:0072008 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.7 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.7 | 15.8 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.7 | 4.8 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 2.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.7 | 6.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.7 | 5.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 4.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.7 | 4.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 4.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.7 | 11.5 | GO:0009650 | UV protection(GO:0009650) |
0.7 | 2.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.7 | 2.7 | GO:0042436 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.7 | 11.9 | GO:0098743 | cell aggregation(GO:0098743) |
0.7 | 13.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.7 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 1.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 9.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.6 | 16.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.6 | 29.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 1.9 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.6 | 1.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.6 | 6.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.6 | 8.4 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.6 | 3.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.6 | 9.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.6 | 7.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.6 | 1.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.6 | 2.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.6 | 10.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.6 | 5.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 13.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.6 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.6 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.6 | 5.0 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.6 | 5.0 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.6 | 5.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.6 | 23.5 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.6 | 6.1 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 1.2 | GO:1990266 | neutrophil migration(GO:1990266) |
0.6 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 1.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.6 | 4.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.6 | 4.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 23.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.6 | 4.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 8.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.6 | 20.6 | GO:0021762 | substantia nigra development(GO:0021762) |
0.6 | 4.1 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.6 | 4.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.6 | 30.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.6 | 4.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 27.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 3.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.6 | 1.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 6.9 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.6 | 2.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 1.7 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 1.7 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.6 | 25.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 10.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 3.4 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.6 | 1.1 | GO:1902617 | response to fluoride(GO:1902617) |
0.6 | 138.8 | GO:0002250 | adaptive immune response(GO:0002250) |
0.6 | 2.8 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
0.6 | 2.2 | GO:0072166 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) negative regulation of glomerulus development(GO:0090194) negative regulation of cell proliferation involved in kidney development(GO:1901723) negative regulation of female gonad development(GO:2000195) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.6 | 3.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.6 | 2.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.5 | 3.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.5 | 3.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.5 | 4.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 3.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.5 | 3.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.5 | 1.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.5 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 1.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 7.4 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 3.7 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.5 | 3.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.5 | 7.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.5 | 2.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.5 | 5.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.5 | 4.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 5.7 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.5 | 4.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.5 | 2.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.5 | 2.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.5 | 3.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.5 | 4.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.5 | 5.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 2.0 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.5 | 1.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.5 | 3.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 10.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.5 | 4.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 4.4 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.5 | 7.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 2.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.5 | 2.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.5 | 2.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.5 | 4.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 1.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 2.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 22.1 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.5 | 3.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.5 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.5 | 28.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 2.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 21.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.5 | 8.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 2.8 | GO:0070977 | bone maturation(GO:0070977) |
0.5 | 1.8 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.5 | 2.8 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.5 | 2.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 8.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.5 | 17.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 3.2 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 5.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.5 | 2.3 | GO:0060087 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 2.2 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.4 | 6.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 2.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 3.1 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.4 | 0.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 3.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 10.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 7.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 2.2 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.4 | 3.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 5.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.4 | 13.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.4 | 2.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.4 | 8.1 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.4 | 3.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 2.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 2.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 5.9 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.4 | 28.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 1.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 2.5 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.4 | 3.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 2.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.4 | 2.9 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.4 | 7.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.4 | 12.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.4 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 8.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.4 | 8.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.4 | 0.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.4 | 5.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.4 | 1.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.4 | 17.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 53.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 7.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 10.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.4 | 1.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 8.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 1.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.4 | 1.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 2.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.4 | 5.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 21.0 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.4 | 15.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.4 | 3.4 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.4 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 0.4 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.4 | 3.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.4 | 7.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.4 | 3.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 10.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.4 | 7.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 7.7 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.4 | 1.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.4 | 1.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.4 | 0.7 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 2.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 5.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 7.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 6.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 2.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 1.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.3 | 11.5 | GO:0003407 | neural retina development(GO:0003407) |
0.3 | 5.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 7.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.3 | 3.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 0.7 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
0.3 | 0.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 1.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.3 | 4.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 1.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 0.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.3 | 8.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 22.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 2.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 2.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 7.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 2.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.3 | 1.6 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.3 | 0.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 3.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.6 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 0.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.3 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 11.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 5.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 8.5 | GO:0097484 | dendrite extension(GO:0097484) |
0.3 | 1.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.3 | 2.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 3.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 2.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.3 | 20.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.3 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 3.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.3 | 9.8 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 3.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 3.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.8 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.3 | 2.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 4.9 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 4.8 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.3 | 3.4 | GO:0043217 | myelin maintenance(GO:0043217) |
0.3 | 4.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 2.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.5 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.2 | 1.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 2.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 1.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 3.0 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.2 | 0.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 8.7 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.2 | 1.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 8.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 6.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 3.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 2.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 1.5 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 6.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.6 | GO:0071600 | otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.2 | 0.6 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) negative regulation of neutrophil degranulation(GO:0043314) regulation of neutrophil activation(GO:1902563) negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.2 | 2.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 5.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 3.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 1.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 2.6 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 0.8 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 4.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.0 | GO:0010816 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 4.6 | GO:0030317 | sperm motility(GO:0030317) |
0.2 | 0.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.9 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 1.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 0.9 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 7.6 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.2 | 1.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 3.8 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 4.8 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.2 | 1.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.3 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.2 | 2.4 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 2.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 4.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.2 | 75.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.2 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 3.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 2.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 4.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.5 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 2.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.6 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.9 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 1.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 2.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.9 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 1.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 2.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 2.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 1.3 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 0.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 1.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.3 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
0.1 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 2.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.5 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 5.6 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 0.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.1 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 1.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.4 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.3 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 1.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:1900619 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.8 | 243.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
10.0 | 59.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
9.5 | 152.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
8.1 | 24.3 | GO:0044609 | DBIRD complex(GO:0044609) |
6.4 | 25.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
5.8 | 23.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
5.6 | 27.9 | GO:0036398 | TCR signalosome(GO:0036398) |
5.4 | 16.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
4.7 | 9.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
4.6 | 18.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
4.5 | 27.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
4.1 | 24.4 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
4.0 | 12.1 | GO:0097679 | other organism cytoplasm(GO:0097679) |
3.9 | 11.8 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
3.7 | 14.9 | GO:0097179 | protease inhibitor complex(GO:0097179) |
3.7 | 47.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.5 | 10.6 | GO:0034455 | t-UTP complex(GO:0034455) |
3.5 | 3.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
3.3 | 6.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.0 | 9.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.9 | 8.7 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
2.8 | 25.6 | GO:0032010 | phagolysosome(GO:0032010) |
2.8 | 36.6 | GO:0042583 | chromaffin granule(GO:0042583) |
2.7 | 13.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.6 | 7.9 | GO:0034657 | GID complex(GO:0034657) |
2.6 | 13.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
2.5 | 20.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
2.5 | 27.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.5 | 14.7 | GO:0033269 | internode region of axon(GO:0033269) |
2.4 | 23.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
2.4 | 40.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
2.3 | 7.0 | GO:0000801 | central element(GO:0000801) |
2.3 | 55.2 | GO:0044295 | axonal growth cone(GO:0044295) |
2.3 | 11.5 | GO:0001652 | granular component(GO:0001652) |
2.2 | 24.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
2.2 | 28.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
2.2 | 6.6 | GO:0032116 | SMC loading complex(GO:0032116) |
2.2 | 15.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
2.2 | 2.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.1 | 14.6 | GO:1990745 | EARP complex(GO:1990745) |
2.1 | 8.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
2.0 | 12.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.9 | 19.5 | GO:0042629 | mast cell granule(GO:0042629) |
1.9 | 19.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.9 | 5.8 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
1.9 | 7.7 | GO:1990879 | CST complex(GO:1990879) |
1.9 | 7.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.9 | 15.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.9 | 9.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.9 | 16.8 | GO:0033270 | paranode region of axon(GO:0033270) |
1.9 | 7.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.8 | 45.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 14.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.8 | 7.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
1.8 | 15.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.8 | 39.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.7 | 22.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.7 | 8.6 | GO:0044308 | axonal spine(GO:0044308) |
1.7 | 8.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.7 | 5.1 | GO:0098536 | deuterosome(GO:0098536) |
1.7 | 10.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.7 | 83.0 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
1.7 | 9.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.6 | 4.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.6 | 57.4 | GO:0071565 | nBAF complex(GO:0071565) |
1.6 | 163.7 | GO:0030315 | T-tubule(GO:0030315) |
1.6 | 4.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.6 | 4.8 | GO:0033167 | ARC complex(GO:0033167) |
1.6 | 11.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.6 | 15.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.6 | 7.9 | GO:0042588 | zymogen granule(GO:0042588) |
1.6 | 9.4 | GO:0043196 | varicosity(GO:0043196) |
1.6 | 6.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.5 | 3.1 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
1.5 | 12.3 | GO:0035976 | AP1 complex(GO:0035976) |
1.5 | 24.2 | GO:0031045 | dense core granule(GO:0031045) |
1.5 | 4.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
1.4 | 18.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.4 | 8.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.4 | 7.1 | GO:0005652 | nuclear lamina(GO:0005652) |
1.4 | 5.7 | GO:0070876 | SOSS complex(GO:0070876) |
1.4 | 13.8 | GO:0005955 | calcineurin complex(GO:0005955) |
1.4 | 16.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
1.4 | 65.5 | GO:0097542 | ciliary tip(GO:0097542) |
1.3 | 6.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
1.3 | 32.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 5.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.3 | 6.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.3 | 15.4 | GO:0030897 | HOPS complex(GO:0030897) |
1.3 | 3.8 | GO:0032009 | early phagosome(GO:0032009) |
1.3 | 1.3 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
1.3 | 5.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.3 | 5.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.2 | 13.7 | GO:0042587 | glycogen granule(GO:0042587) |
1.2 | 7.3 | GO:0033179 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.2 | 13.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.2 | 3.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.2 | 10.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.2 | 3.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.2 | 3.5 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
1.2 | 3.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.1 | 7.9 | GO:0071439 | clathrin complex(GO:0071439) |
1.1 | 2.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.1 | 52.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.1 | 12.3 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 3.3 | GO:0016938 | kinesin I complex(GO:0016938) |
1.1 | 4.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
1.1 | 4.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
1.1 | 18.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 6.4 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 3.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
1.1 | 2.1 | GO:0097513 | myosin II filament(GO:0097513) |
1.1 | 4.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
1.1 | 5.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.1 | 9.5 | GO:0043194 | axon initial segment(GO:0043194) |
1.1 | 3.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.0 | 2.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.0 | 14.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 28.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.0 | 11.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 12.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 34.8 | GO:0008305 | integrin complex(GO:0008305) |
1.0 | 11.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 9.5 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 3.8 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.9 | 4.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.9 | 1.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.9 | 3.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 84.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.9 | 5.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.9 | 2.7 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.9 | 15.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.9 | 15.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.9 | 2.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.9 | 12.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.8 | 1.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.8 | 15.9 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 10.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 8.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.8 | 15.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.8 | 3.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 3.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.8 | 3.3 | GO:0035841 | new growing cell tip(GO:0035841) |
0.8 | 9.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.8 | 130.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 4.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.8 | 4.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.8 | 4.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.8 | 2.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.8 | 18.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.8 | 29.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 3.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.8 | 36.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.8 | 6.9 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.7 | 5.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.7 | 7.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.7 | 2.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.7 | 2.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 7.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 2.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 50.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 30.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.7 | 7.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 14.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 2.0 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.7 | 8.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 4.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.7 | 5.4 | GO:0097433 | dense body(GO:0097433) |
0.7 | 122.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 9.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 18.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 4.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.7 | 2.0 | GO:0005592 | collagen type XI trimer(GO:0005592) |
0.6 | 5.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.6 | 22.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.6 | 9.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 22.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.6 | 1.9 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.6 | 15.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 22.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.6 | 3.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 50.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.6 | 4.9 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 8.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 4.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 6.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 8.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 2.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.6 | 8.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.6 | 4.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 8.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.6 | 25.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 2.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 9.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 1.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 38.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 5.9 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 1.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 2.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.5 | 14.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 3.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 2.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 5.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 100.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 30.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 5.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 3.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 0.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 1.9 | GO:0044307 | dendritic branch(GO:0044307) |
0.5 | 3.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 63.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 6.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 6.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.4 | 114.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 5.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 2.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 35.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.4 | 4.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 1.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.4 | 20.2 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 19.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 31.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 2.0 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 3.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 10.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.3 | 6.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.3 | 4.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 0.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.3 | 2.8 | GO:0070449 | elongin complex(GO:0070449) |
0.3 | 1.9 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 24.9 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 2.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 25.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 6.6 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 2.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 40.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 3.1 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 3.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 3.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 9.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 27.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.4 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 2.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 3.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 3.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 12.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.9 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 2.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 9.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 2.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 137.0 | GO:0045202 | synapse(GO:0045202) |
0.2 | 16.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 5.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 0.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.2 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 2.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 3.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 5.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 4.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 3.6 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 149.9 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 3.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 2.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 2.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 104.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 8.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 3.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.8 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 3.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 1.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 1.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 29.5 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.1 | 84.2 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
12.9 | 38.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
8.9 | 62.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
8.1 | 32.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
7.2 | 28.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
6.7 | 40.0 | GO:0070728 | leucine binding(GO:0070728) |
6.5 | 91.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
6.2 | 24.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
6.1 | 18.2 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
6.0 | 18.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
5.9 | 29.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
5.9 | 17.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
5.8 | 23.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
5.8 | 17.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
5.7 | 45.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
5.6 | 28.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
5.5 | 16.6 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
5.4 | 92.5 | GO:0031432 | titin binding(GO:0031432) |
5.4 | 80.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.2 | 20.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.1 | 20.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
5.0 | 29.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
4.9 | 29.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
4.9 | 146.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
4.7 | 130.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
4.5 | 18.2 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
4.5 | 13.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
4.5 | 18.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
4.5 | 18.0 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
4.4 | 31.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
4.3 | 25.8 | GO:0008142 | oxysterol binding(GO:0008142) |
4.3 | 21.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
4.2 | 59.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
4.1 | 12.2 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
4.1 | 48.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
4.0 | 20.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
4.0 | 12.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
4.0 | 12.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
3.9 | 19.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.9 | 15.5 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
3.8 | 11.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
3.8 | 18.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
3.7 | 11.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
3.7 | 43.8 | GO:0008430 | selenium binding(GO:0008430) |
3.6 | 14.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
3.6 | 50.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
3.6 | 14.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
3.6 | 14.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
3.6 | 17.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
3.4 | 30.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
3.4 | 13.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
3.3 | 13.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
3.3 | 13.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.2 | 16.1 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
3.2 | 12.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
3.1 | 12.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
3.1 | 47.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
3.1 | 12.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
3.1 | 24.8 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
3.1 | 34.0 | GO:0019864 | IgG binding(GO:0019864) |
3.0 | 27.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.9 | 20.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.9 | 8.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.8 | 22.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.8 | 13.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
2.7 | 10.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
2.7 | 8.1 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
2.6 | 10.5 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
2.6 | 2.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
2.6 | 7.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
2.6 | 7.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
2.5 | 10.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
2.5 | 5.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
2.5 | 17.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
2.5 | 29.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
2.5 | 12.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.5 | 19.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.4 | 4.9 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
2.4 | 7.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
2.4 | 11.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
2.3 | 16.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.3 | 18.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.3 | 29.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.3 | 6.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.3 | 6.8 | GO:0016497 | substance K receptor activity(GO:0016497) |
2.2 | 2.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.2 | 13.2 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
2.2 | 10.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.2 | 6.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
2.2 | 13.0 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
2.2 | 6.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
2.2 | 4.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.2 | 6.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.1 | 6.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
2.1 | 6.4 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
2.1 | 14.8 | GO:0030911 | TPR domain binding(GO:0030911) |
2.1 | 8.4 | GO:0035473 | lipase binding(GO:0035473) |
2.1 | 16.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.1 | 6.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
2.0 | 8.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
2.0 | 8.0 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
2.0 | 8.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.0 | 6.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
2.0 | 15.7 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
2.0 | 9.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.9 | 17.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.9 | 13.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.9 | 11.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.9 | 7.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.9 | 16.9 | GO:0033691 | sialic acid binding(GO:0033691) |
1.9 | 7.5 | GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
1.9 | 5.6 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
1.9 | 16.8 | GO:0009374 | biotin binding(GO:0009374) |
1.9 | 9.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.9 | 363.0 | GO:0003823 | antigen binding(GO:0003823) |
1.9 | 5.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.8 | 11.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.8 | 12.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.8 | 46.6 | GO:0043274 | phospholipase binding(GO:0043274) |
1.8 | 12.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.8 | 7.1 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
1.8 | 8.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.8 | 5.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.8 | 19.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.7 | 3.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
1.7 | 153.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.7 | 13.9 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.7 | 5.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
1.7 | 20.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.7 | 12.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.7 | 6.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
1.7 | 8.5 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
1.7 | 11.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.7 | 5.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.7 | 1.7 | GO:0043559 | insulin binding(GO:0043559) |
1.7 | 3.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
1.7 | 10.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.7 | 1.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
1.7 | 26.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.6 | 9.9 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.6 | 29.5 | GO:0038191 | neuropilin binding(GO:0038191) |
1.6 | 8.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.6 | 6.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.6 | 41.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.6 | 4.8 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
1.6 | 12.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.6 | 19.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.6 | 1.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.6 | 20.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.6 | 25.1 | GO:0016918 | retinal binding(GO:0016918) |
1.6 | 4.7 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
1.6 | 32.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.6 | 7.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.6 | 4.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.6 | 4.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.5 | 19.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.5 | 6.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.5 | 15.1 | GO:0005549 | odorant binding(GO:0005549) |
1.5 | 19.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.5 | 7.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.5 | 6.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.5 | 6.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.5 | 1.5 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
1.5 | 4.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.5 | 31.0 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
1.4 | 11.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.4 | 5.8 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
1.4 | 10.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.4 | 5.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.4 | 12.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 4.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.4 | 7.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.4 | 18.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.4 | 11.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 62.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.4 | 1.4 | GO:0032356 | oxidized DNA binding(GO:0032356) |
1.4 | 26.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
1.4 | 5.5 | GO:0097001 | glycolipid transporter activity(GO:0017089) ceramide binding(GO:0097001) |
1.4 | 4.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.4 | 38.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 58.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.4 | 16.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.4 | 10.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.4 | 4.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.4 | 19.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.4 | 9.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.4 | 6.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.3 | 5.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
1.3 | 25.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.3 | 37.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.3 | 2.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.3 | 5.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.3 | 8.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.3 | 13.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
1.3 | 4.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.3 | 14.6 | GO:0048156 | tau protein binding(GO:0048156) |
1.3 | 6.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
1.3 | 11.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.3 | 7.8 | GO:0017040 | ceramidase activity(GO:0017040) |
1.3 | 72.9 | GO:0030507 | spectrin binding(GO:0030507) |
1.3 | 3.9 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
1.3 | 11.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.3 | 5.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
1.3 | 3.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.3 | 17.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 3.8 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.3 | 7.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.3 | 6.3 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.3 | 12.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 10.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 8.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.2 | 5.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.2 | 7.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.2 | 27.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.2 | 10.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.2 | 24.9 | GO:0070403 | NAD+ binding(GO:0070403) |
1.2 | 11.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.2 | 3.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.2 | 20.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
1.2 | 3.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.2 | 11.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.2 | 6.9 | GO:0030172 | troponin C binding(GO:0030172) |
1.2 | 32.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 5.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.1 | 28.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 8.0 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 4.6 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
1.1 | 4.6 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.1 | 5.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.1 | 23.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.1 | 4.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.1 | 7.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.1 | 4.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.1 | 23.9 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
1.1 | 100.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
1.1 | 2.2 | GO:0042806 | fucose binding(GO:0042806) |
1.1 | 4.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.1 | 3.2 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
1.1 | 5.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.0 | 21.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.0 | 3.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.0 | 3.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.0 | 13.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.0 | 11.4 | GO:0031433 | telethonin binding(GO:0031433) |
1.0 | 4.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.0 | 20.6 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 15.3 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
1.0 | 24.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.0 | 29.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.0 | 5.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.0 | 3.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.0 | 6.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.0 | 4.0 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.0 | 3.0 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
1.0 | 5.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.0 | 2.9 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.0 | 4.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.0 | 8.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
1.0 | 6.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.0 | 30.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.0 | 9.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.0 | 3.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 23.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 3.8 | GO:0061656 | HLH domain binding(GO:0043398) SUMO conjugating enzyme activity(GO:0061656) |
0.9 | 4.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.9 | 2.8 | GO:0052853 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.9 | 2.8 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.9 | 5.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 3.7 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.9 | 7.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.9 | 3.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 5.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.9 | 2.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.9 | 4.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.9 | 11.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.9 | 6.4 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.9 | 11.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.9 | 11.9 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.9 | 29.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.9 | 34.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.9 | 3.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.9 | 4.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 3.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 14.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.9 | 3.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.9 | 6.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 7.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.9 | 0.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.9 | 13.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.9 | 5.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.9 | 1.7 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.9 | 3.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.9 | 2.6 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.9 | 16.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.8 | 5.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.8 | 5.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.8 | 6.7 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.8 | 2.5 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.8 | 7.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 10.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 3.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.8 | 2.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.8 | 5.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.8 | 8.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 2.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 9.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 42.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.8 | 3.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 4.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.8 | 4.8 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.8 | 4.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 3.2 | GO:0004341 | gluconolactonase activity(GO:0004341) |
0.8 | 4.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 20.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 7.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.8 | 9.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.8 | 15.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.8 | 18.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 4.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.8 | 1.5 | GO:0019841 | retinol binding(GO:0019841) |
0.8 | 6.8 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 2.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 3.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 6.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 16.5 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.7 | 2.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 9.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.7 | 14.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.7 | 2.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.7 | 5.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.7 | 12.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 3.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 2.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 4.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 22.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 4.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 12.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 2.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.7 | 3.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.7 | 7.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.7 | 4.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 3.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 9.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.7 | 14.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 2.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.7 | 9.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 4.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.7 | 65.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 11.9 | GO:0070513 | death domain binding(GO:0070513) |
0.7 | 5.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 2.0 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.7 | 3.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 17.6 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 12.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.6 | 6.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 1.9 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.6 | 10.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.6 | 2.5 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.6 | 7.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 1.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 20.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 3.8 | GO:0039552 | RIG-I binding(GO:0039552) |
0.6 | 10.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 6.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 1.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
0.6 | 1.8 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.6 | 7.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 3.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 18.7 | GO:0043621 | protein self-association(GO:0043621) |
0.6 | 19.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.6 | 1.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 8.4 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 4.2 | GO:0005497 | androgen binding(GO:0005497) |
0.6 | 4.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 3.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 3.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 1.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 4.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 1.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.6 | 3.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.6 | 2.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 5.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.6 | 3.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.6 | 2.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 8.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.6 | 1.7 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
0.6 | 3.9 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 3.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.5 | 1.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 8.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 56.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 3.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 2.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.5 | 183.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.5 | 2.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 53.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.5 | 8.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.5 | 3.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 13.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 10.0 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.5 | 13.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 10.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 27.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 2.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 13.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 4.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 7.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 4.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 2.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 5.6 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.5 | 2.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 7.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 13.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 2.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 7.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.5 | 2.0 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 13.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 3.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 2.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 4.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.5 | 2.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.5 | 10.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 3.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 6.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.5 | 27.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 1.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.5 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 7.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.5 | 0.5 | GO:0070697 | activin receptor binding(GO:0070697) |
0.5 | 0.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 4.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 5.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 17.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.5 | 4.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 1.4 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.5 | 4.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 18.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 5.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 9.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 3.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 4.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.4 | 2.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 2.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.4 | 1.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 7.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 2.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 3.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 9.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.4 | 3.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.4 | 4.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 7.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 2.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.4 | 2.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 10.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 2.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 1.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 12.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 3.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 1.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 3.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 7.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 3.7 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 4.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 1.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.4 | 1.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.4 | 0.4 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.4 | 1.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 3.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.3 | 1.4 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 0.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.3 | 4.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 2.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 6.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 8.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 2.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 5.8 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 0.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 1.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.3 | 24.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.3 | 2.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 3.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 5.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 6.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 2.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 2.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 1.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 2.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 4.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 7.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 2.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 6.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 2.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 14.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.3 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 6.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 3.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 6.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 2.1 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 7.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 2.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 2.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 3.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 6.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 12.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 1.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 11.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 5.3 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 15.8 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 2.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 0.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.2 | 1.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 2.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 1.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 35.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 2.9 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 14.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.5 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
0.1 | 1.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 2.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.6 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 2.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 5.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.1 | GO:0099589 | serotonin receptor activity(GO:0099589) |
0.1 | 0.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.5 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 126.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 2.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.1 | 1.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 3.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.0 | 0.6 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.1 | GO:0005261 | cation channel activity(GO:0005261) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.3 | 129.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
2.3 | 52.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.9 | 102.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.9 | 87.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.8 | 63.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.7 | 67.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.7 | 1.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.5 | 32.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.5 | 10.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.3 | 19.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.2 | 55.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.2 | 3.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.2 | 37.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.2 | 34.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.1 | 5.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.1 | 12.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.1 | 12.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.1 | 46.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 63.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.0 | 4.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.0 | 4.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
1.0 | 29.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 14.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 1.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 24.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 2.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 4.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 19.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 21.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.7 | 13.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.7 | 4.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 19.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.7 | 129.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 12.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 14.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 6.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 14.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.6 | 20.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.6 | 15.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 13.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 24.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 9.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 8.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.6 | 12.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 38.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.6 | 13.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 18.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 7.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 8.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 6.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 10.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 15.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 6.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 5.8 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 4.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 1.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 30.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 10.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 28.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 10.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 11.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 23.7 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 5.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 2.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 5.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 5.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 5.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 29.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 6.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 10.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 8.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 12.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 23.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 7.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 5.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 4.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 55.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 7.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 4.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 16.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 12.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 4.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 42.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 2.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 12.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 4.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 2.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 193.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
4.5 | 31.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
3.4 | 58.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
3.0 | 9.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.6 | 58.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.6 | 31.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
2.4 | 53.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
2.4 | 31.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.2 | 8.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.0 | 24.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.0 | 3.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.9 | 50.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.9 | 165.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.9 | 38.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.8 | 1.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.8 | 19.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.7 | 25.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.7 | 62.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.6 | 12.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.5 | 3.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.5 | 7.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.5 | 61.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.4 | 32.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.3 | 43.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 17.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.3 | 36.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.3 | 8.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.2 | 14.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.2 | 12.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.2 | 52.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.2 | 76.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.2 | 27.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.2 | 29.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.2 | 12.7 | REACTOME OPSINS | Genes involved in Opsins |
1.1 | 5.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.1 | 25.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.1 | 7.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 2.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.0 | 15.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.0 | 46.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.0 | 22.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.0 | 9.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 39.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.9 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.9 | 23.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.9 | 8.4 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.9 | 4.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.9 | 23.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.9 | 5.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.9 | 19.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 43.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.9 | 14.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 81.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.9 | 6.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 2.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.9 | 6.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 20.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.8 | 2.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 24.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 16.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 7.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 11.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 3.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 9.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.7 | 6.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 6.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 44.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 15.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.7 | 13.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 19.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 5.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.7 | 4.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 19.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 27.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 4.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 7.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 7.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 23.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 3.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.6 | 4.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 9.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 6.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 17.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.6 | 74.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 76.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 9.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 12.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 19.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 10.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 45.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 48.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.5 | 11.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 3.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.5 | 26.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 7.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 19.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 190.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.4 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 7.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 15.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 3.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 3.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 4.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 26.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 6.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 8.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 9.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 5.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 7.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 1.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 1.4 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.3 | 4.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 2.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 4.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.3 | 5.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 5.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 2.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 1.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 12.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 7.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 2.5 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.3 | 9.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 2.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 2.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 4.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 24.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 3.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 11.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 4.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 4.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 12.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 12.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 1.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 4.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 10.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 3.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 3.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 2.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 4.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 2.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.5 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 1.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 4.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |